Dysregulation of the MIRLET7/HMGA2 axis with methylation of the CDKN2A promoter in myeloproliferative neoplasms

Publisher： John Wiley & Sons Inc

E-ISSN： 1365-2141|168|3|338-349

ISSN： 0007-1048

Source： BRITISH JOURNAL OF HAEMATOLOGY, Vol.168, Iss.3, 2015-02, pp. : 338-349

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

JAK2 and MPL Mutations in Myeloproliferative Neoplasms

By  

Acta Haematologica, Vol. 119, Iss. 4, 2008-06 ,pp. : 218-225

Karger

Access to resources Recommend Favorite

Quantitative Comparison of CDKN2B Methylation in Pediatric and Adult Myelodysplastic Syndromes

By  

Acta Haematologica, Vol. 130, Iss. 2, 2013-04 ,pp. : 115-121

Karger

Access to resources Recommend Favorite

Clinical and Laboratory Significance of Defective P2Y12 Pathway Function in Patients with Myeloproliferative Neoplasms: A Pilot Study

By  

Acta Haematologica, Vol. 130, Iss. 3, 2013-06 ,pp. : 181-187

Karger

Access to resources Recommend Favorite

Frequency and Molecular Characteristics of Calreticulin Gene (CALR) Mutations in Patients with JAK2-Negative Myeloproliferative Neoplasms

By  

Acta Haematologica, Vol. 133, Iss. 2, 2014-10 ,pp. : 193-198

Karger

Access to resources Recommend Favorite

RhoBTB2 gene in breast cancer is silenced by promoter methylation

By        

International Journal of Molecular Medicine, Vol. 33, Iss. 3, 2014-01 ,pp. : 722-728

Spandidos Publications

Access to resources Recommend Favorite